|
1
|
Spence-Shishido AA, Good WV, Baselga E and
Frieden IJ: Hemangiomas and the eye. Clin Dermatol. 33:170–182.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Phillips JD, Zhang H, Wei T and Richter
GT: Expression of β-adrenergic receptor subtypes in proliferative,
involuted, and propranolol-responsive infantile hemangiomas. JAMA
Facial Plast Surg. 19:102–107. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Janmohamed SR, Madern GC, de Laat PC and
Oranje AP: Educational paper: Pathogenesis of infantile
haemangioma, an update 2014 (part I). Eur J Pediatr. 174:97–103.
2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Nakayama H, Huang L, Kelly RP, Oudenaarden
CR, Dagher A, Hofmann NA, Moses MA, Bischoff J and Klagsbrun M:
Infantile hemangioma-derived stem cells and endothelial cells are
inhibited by class 3 semaphorins. Biochem Biophys Res Commun.
464:126–132. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Itinteang T, Davis PF and Tan ST:
Infantile hemangiomas exhibit neural crest and pericyte markers.
Ann Plast Surg. 74(383)2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Koshizuka K, Nohata N, Hanazawa T, Kikkawa
N, Arai T, Okato A, Fukumoto I, Katada K, Okamoto Y and Seki N:
Deep sequencing-based microRNA expression signatures in head and
neck squamous cell carcinoma: Dual strands of pre-miR-150 as
antitumor miRNAs. Oncotarget. 8:30288–30304. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Biswas A, Pan X, Meyer M, Khanna S, Roy S,
Pearson G, Kirschner R, Witman P, Faith EF, Sen CK and Gordillo GM:
Urinary excretion of MicroRNA-126 is a biomarker for hemangioma
proliferation. Plast Reconstr Surg. 139(1277e-1284e)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fei Z, Qiu M, Qi X, Dai Y, Wang S, Quan Z,
Liu Y and Ou J: MicroRNA-424 suppresses the proliferation of
hemangioma-derived endothelial cells by targeting VEGFR-2. Mol Med
Rep. 18:4065–4071. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Huang C, Huang J, Ma P and Yu G:
microRNA-143 acts as a suppressor of hemangioma growth by targeting
Bcl-2. Gene. 628:211–217. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mong EF, Akat KM, Canfield J, Lockhart J,
VanWye J, Matar A, Tsibris JCM, Wu JK, Tuschl T and Totary-Jain H:
Modulation of LIN28B/Let-7 signaling by propranolol contributes to
infantile hemangioma involution. Arterioscler Thromb Vasc Biol.
38:1321–1332. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Liu CH, Lv DS, Li M, Sun G, Zhang XF and
Bai Y: MicroRNA-4458 suppresses the proliferation of human lung
cancer cells in vitro by directly targeting Lin28B. Acta Pharmacol
Sin. 38:1297–1304. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tang D, Sun B, Yu H, Yang Z and Zhu L:
Tumor-suppressing effect of miR-4458 on human hepatocellular
carcinoma. Cell Physiol Biochem. 35:1797–1807. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Qin Y, Cheng C, Lu H and Wang Y: miR-4458
suppresses glycolysis and lactate production by directly targeting
hexokinase2 in colon cancer cells. Biochem Biophys Res Commun.
469:37–43. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cai W, Sakaguchi M, Kleinridders A,
Gonzalez-Del Pino G, Dreyfuss JM, O'Neill BT, Ramirez AK, Pan H,
Winnay JN, Boucher J, et al: Domain-dependent effects of insulin
and IGF-1 receptors on signalling and gene expression. Nat Commun.
8(14892)2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cannarella R, Mattina T, Condorelli RA,
Mongioì LM, Pandini G, La Vignera S and Calogero AE: Chromosome 15
structural abnormalities: Effect on IGF1R gene expression and
function. Endocr Connect. 6:528–539. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Taliaferro-Smith LT, Oberlick E, Liu T,
McGlothen T, Alcaide T, Tobin R, Donnelly S, Commander R, Kline E,
Nagaraju GP, et al: FAK activation is required for IGF1R-mediated
regulation of EMT, migration, and invasion in mesenchymal triple
negative breast cancer cells. Oncotarget. 6:4757–4772.
2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ball MW, Bezerra SM, Chaux A, Faraj SF,
Gonzalez-Roibon N, Munari E, Sharma R, Bivalacqua TJ, Netto GJ and
Burnett AL: Overexpression of insulin-like growth factor-1 receptor
is associated with penile cancer progression. Urology. 92:51–56.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Qian Y, Teng Y, Li Y, Lin X, Guan M, Li Y,
Cao X and Gao Y: miR-143-3p suppresses the progression of nasal
squamous cell carcinoma by targeting Bcl-2 and IGF1R. Biochem
Biophys Res Commun. 518:492–499. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zaanan A, Calmel C, Henriques J, Svrcek M,
Blons H, Desbois-Mouthon C, Merabtene F, Goumard C, Parc Y, Gayet
B, et al: High IGF1R protein expression correlates with
disease-free survival of patients with stage III colon cancer. Cell
Oncol (Dordr). Dec 10. 2019.(Epub ahead of print). doi:
10.1007/s13402-019-00484-6. PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang XH, Wu HY, Gao J, Wang XH, Gao TH and
Zhang SF: IGF1R facilitates epithelial-mesenchymal transition and
cancer stem cell properties in neuroblastoma via the STAT3/AKT
axis. Cancer Manag Res. 11:5459–5472. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ou JM, Lian WS, Qiu MK, Dai YX, Dong Q,
Shen J, Dong P, Wang XF, Liu YB, Quan ZW and Fei ZW: Knockdown of
IGF2R suppresses proliferation and induces apoptosis in hemangioma
cells in vitro and in vivo. Int J Oncol. 45:1241–1249.
2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liu ZQ, Fu WQ, Zhao S and Zhao X:
Regulation of insulin-like growth factor 1 receptor signaling by
microRNA-4458 in the development of lumbar disc degeneration. Am J
Transl Res. 8:2309–2316. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fu X, Zhai S and Yuan J: Interleukin-6
(IL-6) triggers the malignancy of hemangioma cells via activation
of HIF-1α/VEGFA signals. Eur J Pharmacol. 41:82–89. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Qiu MK, Wang SQ, Pan C, Wang Y, Quan ZW,
Liu YB and Ou JM: ROCK inhibition as a potential therapeutic target
involved in apoptosis in hemangioma. Oncol Rep. 37:2987–2993.
2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bandres E, Bitarte N, Arias F, Agorreta J,
Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ,
et al: microRNA-451 regulates macrophage migration inhibitory
factor production and proliferation of gastrointestinal cancer
cells. Clin Cancer Res. 15:2281–2290. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bao L, Wang L, Wei G, Wang Y, Wuyun G and
Bo A: Role of microRNA-4458 in patients with non-small-cell lung
cancer. Oncol Lett. 12:3958–3966. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hoffman Y, Bublik DR, Ugalde AP, Elkon R,
Biniashvili T, Agami R, Oren M and Pilpel Y: 3'UTR shortening
potentiates MicroRNA-based repression of pro-differentiation genes
in proliferating human cells. PLoS Genet.
12(e1005879)2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zakraoui O, Marcinkiewicz C, Aloui Z,
Othman H, Grépin R, Haoues M, Essafi M, Srairi-Abid N, Gasmi A,
Karoui H, et al: Lebein, a snake venom disintegrin, suppresses
human colon cancer cells proliferation and tumor-induced
angiogenesis through cell cycle arrest, apoptosis induction and
inhibition of VEGF expression. Mol Carcinog. 56:18–37.
2017.PubMed/NCBI View
Article : Google Scholar
|
|
32
|
Wang S, Wang X, Wu Y and Han C: IGF-1R
signaling is essential for the proliferation of cultured mouse
spermatogonial stem cells by promoting the G2/M progression of the
cell cycle. Stem Cells Dev. 24:471–483. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhang M, Liu J, Li M, Zhang S, Lu Y, Liang
Y, Zhao K and Li Y: Insulin-like growth factor 1/insulin-like
growth factor 1 receptor signaling protects against cell apoptosis
through the PI3K/AKT pathway in glioblastoma cells. Exp Ther Med.
16:1477–1482. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ayub A, Yip WK and Seow HF: Dual
treatments targeting IGF-1R, PI3K, mTORC or MEK synergize to
inhibit cell growth, induce apoptosis, and arrest cell cycle at G1
phase in MDA-MB-231 cell line. Biomed Pharmacother. 75:40–50.
2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Li T, Zhao X, Mo Z, Huang W, Yan H, Ling Z
and Ye Y: Formononetin promotes cell cycle arrest via
downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer
cells. Cell Physiol Biochem. 34:1351–1358. 2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Chen J, Duan Y, Zhang X, Ye Y, Ge B and
Chen J: Genistein induces apoptosis by the inactivation of the
IGF-1R/p-Akt signaling pathway in MCF-7 human breast cancer cells.
Food Funct. 6:995–1000. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Dai Z, Wang L, Wang X, Zhao B, Zhao W,
Bhardwaj SS, Ye J, Yin Z, Zhang J and Zhao S: Oxymatrine induces
cell cycle arrest and apoptosis and suppresses the invasion of
human glioblastoma cells through the EGFR/PI3K/Akt/mTOR signaling
pathway and STAT3. Oncol Rep. 40:867–876. 2018.PubMed/NCBI View Article : Google Scholar
|
